Hayashi, T., Shibata, M., Oe, S., Miyagawa, K., Honma, Y., & Harada, M. (2020). C-reactive protein can predict dose intensity, time to treatment failure and overall survival in HCC treated with lenvatinib. PLoS One.
Citação norma ChicagoHayashi, Tsuguru, Michihiko Shibata, Shinji Oe, Koichiro Miyagawa, Yuichi Honma, and Masaru Harada. "C-reactive Protein Can Predict Dose Intensity, Time to Treatment Failure and Overall Survival in HCC Treated With Lenvatinib." PLoS One 2020.
Citação norma MLAHayashi, Tsuguru, et al. "C-reactive Protein Can Predict Dose Intensity, Time to Treatment Failure and Overall Survival in HCC Treated With Lenvatinib." PLoS One 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.